Compare BridgeBio Pharma Inc (BBIO) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs PayPal Holdings, Inc. — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while PayPal Holdings, Inc. trades at $54.63 (market cap $42.03B). The key difference: PayPal Holdings, Inc. is far larger — about 2.6× BridgeBio Pharma Inc's market cap, and PayPal Holdings, Inc. pays a 1.18% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | PYPL | |
|---|---|---|
Market Cap | $16.27B | $42.03B |
Sector | Health | Financials |
52-Week High | $90.17 | $78.22 |
52-Week Low | $44.81 | $39.08 |
Enterprise Value | $17.82B | $42.10B |
Dividend Yield | — | 1.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PayPal (PYPL) trades at $47.65, up 2.87% on the day, with a bullish technical signal from moving averages but overbought RSI readings near 78. The stock shows strong fundamentals with a P/E of 8.94, net income margin of 15%, and consistent revenue growth to $33.17B in 2025. Recent news includes a potential acquisition offer from Stripe and Advent at $60.50 per share, valuing the company over $53 billion, alongside expansion of BNPL services in the UK.
PYPL presents a compelling value opportunity with low valuation multiples and solid profitability, though execution risks and competitive pressures remain. The acquisition speculation adds upside potential, but investors face volatility from earnings misses and regulatory scrutiny. Wall Street sentiment is mixed with a $48.36 consensus target, slightly above the current price.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
